Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

193,900 studies for “United States”

NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid TumorsRecruiting
NCT07489378N/AUpdated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
Very Rare Tumors · Very Rare Cancers · Other Solid Tumors · Solid Tumor
United States
A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory TreatmentCompleted
NCT07025811Phase 4Updated Jul 27, 2026
Sponsor: Hoffmann-La Roche
Dry Eye Disease
United States
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN StudyRecruiting
NCT05987241Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
Muscle Invasive Bladder Urothelial Carcinoma · Muscle Invasive Renal Pelvis Urothelial Carcinoma · Muscle Invasive Ureter Urothelial Carcinoma · Muscle Invasive Urethral Urothelial Carcinoma
United States, Canada
Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus InfectionRecruiting
NCT07706686Phase 1Updated Jul 27, 2026
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Healthy Volunteers · Dengue · Human Challenge Trial
United States
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)Recruiting
NCT06395103Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
B-cell Acute Lymphoblastic Leukemia · Diffuse Large B-cell Lymphoma · Burkitt Lymphoma · Neuroblastoma
United States, Australia, Belgium, Brazil, Canada +18 more
Pain Alleviation With Testosterone in Opioid-Induced HypogonadismRecruiting
NCT04798469Phase 2Updated Jul 27, 2026
Sponsor: Brigham and Women's Hospital
Opioid Use · Pain · Hypogonadism, Male
United States
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain MetastasesNot Yet Recruiting
NCT07619534N/AUpdated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
Breast Cancer · Breast Carcinoma · Cancer of the Breast · Malignant Neoplasm of Breast
United States
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent GlioblastomaRecruiting
NCT07416188Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recurrent Glioblastoma · Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype · Relapsed Cancer · Recurrent Tumor
United States
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseaseRecruiting
NCT07363694Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Pfizer
Moderate to Severe Chronic Obstructive Pulmonary Disease
United States, Argentina, Canada, China, India +3 more
Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation TrialRecruiting
NCT06931821NAUpdated Jul 27, 2026
Sponsor: University of Arizona
Sustained Monomorphic VT (MMVT) · Recurrent Ventricular Tachycardia
United States
RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the KneeActive Not Recruiting
NCT05318521Phase 3Updated Jul 27, 2026
Sponsor: Overseas Pharmaceuticals, Ltd.
Degenerative Arthritis
United States, Taiwan
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck CancerSuspended
NCT01810913Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma · Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 · Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 · Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
United States, Canada, Hong Kong
Improving Cognitive Function in Older Adults Undergoing Stem Cell TransplantRecruiting
NCT04898790NAUpdated Jul 27, 2026
Sponsor: University of Nebraska
Leukemia · Lymphoma · Multiple Myeloma · Myelodysplastic Syndromes (MDS)
United States
Tissue Preservation in Immediate 1C Implants Using an Anatomical Prefabricated Healing AbutmentNot Yet Recruiting
NCT07727980NAUpdated Jul 27, 2026
Sponsor: University of Illinois at Chicago
Tooth Loss · Dental Implant · Clinical Trials · Randomized Controlled Trial
United States
Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERDCompleted
NCT05556824Phase 2Updated Jul 27, 2026
Sponsor: Microbiome Health Sciences
Gastroesophageal Reflux
United States
A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's DiseaseActive Not Recruiting
NCT07106021Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: Kenai Therapeutics
Idiopathic Parkinson´s Disease · Parkinson's Disease
United States
Comparison of CE-DBT and MRI in Patients With Known Breast LesionsTerminated
NCT05754749EARLY_Phase 1Updated Jul 27, 2026
Sponsor: UNC Lineberger Comprehensive Cancer Center
Breast Cancer
United States
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical CancerRecruiting
NCT07061977Phase 3Updated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
Locally Advanced Cervical Adenocarcinoma · Locally Advanced Cervical Adenosquamous Carcinoma · Locally Advanced Cervical Squamous Cell Carcinoma · Stage IIIA Cervical Cancer FIGO 2018
United States
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial)Active Not Recruiting
NCT06129539Phase 3Updated Jul 27, 2026
Sponsor: Debiopharm International SA
Central Precocious Puberty
United States, Argentina, Brazil, Chile, Mexico
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE TrialRecruiting
NCT06184750Phase 2Updated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
Breast Atypical Ductal Hyperplasia · Breast Atypical Lobular Hyperplasia · Breast Carcinoma · Breast Ductal Carcinoma In Situ
United States
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' DiseaseRecruiting
NCT07018323Phase 2Updated Jul 27, 2026
Sponsor: Immunovant Sciences GmbH
Graves' Disease
United States, Australia, Brazil, Bulgaria, Chile +12 more
Oral Surgery Virtual Reality Glasses StudyRecruiting
NCT06723158NAUpdated Jul 27, 2026
Sponsor: Boston University
Procedural Anxiety · Procedural Pain
United States
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...Recruiting
NCT05621291NAUpdated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
B-All · Acute Lymphoblastic Leukemia
United States
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)Recruiting
NCT01419561Phase 2Updated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
KSHV Inflammatory Cytokine Syndrome (KICS) · KSHV · HHV-8
United States
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.Recruiting
NCT07494305Phase 2Updated Jul 27, 2026
Sponsor: LB Pharmaceuticals Inc.
Bipolar I Disorder
United States

193,900 studies found